Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.

Marti M, Mela F, Veronesi C, Guerrini R, Salvadori S, Federici M, Mercuri NB, Rizzi A, Franchi G, Beani L, Bianchi C, Morari M.

J Neurosci. 2004 Jul 28;24(30):6659-66.

2.

UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.

Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, Regoli D.

CNS Drug Rev. 2005 Summer;11(2):97-112. Review.

3.

Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.

Chiou LC, Fan SH, Chuang KC, Liao YY, Lee SZ.

Ann N Y Acad Sci. 2004 Oct;1025:398-403. Review.

PMID:
15542742
4.

The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.

Pharmacol Ther. 2014 Mar;141(3):283-99. doi: 10.1016/j.pharmthera.2013.10.011. Epub 2013 Nov 1. Review. Erratum in: Pharmacol Ther. 2014 Sep;143(3):351.

PMID:
24189487
5.
6.

Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.

Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP.

Curr Drug Targets. 2007 Jan;8(1):117-35. Review.

PMID:
17266536
7.

GABAergic control of substantia nigra dopaminergic neurons.

Tepper JM, Lee CR.

Prog Brain Res. 2007;160:189-208. Review.

PMID:
17499115
8.

Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.

Gavioli EC, Calo' G.

Pharmacol Ther. 2013 Oct;140(1):10-25. doi: 10.1016/j.pharmthera.2013.05.008. Epub 2013 May 24. Review.

PMID:
23711793
9.

Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.

Meunier JC.

Eur J Pharmacol. 1997 Dec 4;340(1):1-15. Review.

PMID:
9527501
10.

Nociceptin/orphanin FQ: actions within the brain.

Meis S.

Neuroscientist. 2003 Apr;9(2):158-68. Review.

PMID:
12708619
11.

Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect.

Ciccocioppo R, Cippitelli A, Economidou D, Fedeli A, Massi M.

Physiol Behav. 2004 Aug;82(1):63-8. Review.

PMID:
15234592
12.

UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.

Calo' G, Rizzi A, Cifani C, Micioni Di Bonaventura MV, Regoli D, Massi M, Salvadori S, Lambert DG, Guerrini R.

CNS Neurosci Ther. 2011 Jun;17(3):178-98. doi: 10.1111/j.1755-5949.2009.00107.x. Epub 2010 May 18. Review.

PMID:
20497197
13.

Basal ganglia control of substantia nigra dopaminergic neurons.

Lee CR, Tepper JM.

J Neural Transm Suppl. 2009;(73):71-90. Review.

PMID:
20411769
14.

Orphanin FQ/nociceptin: from neural circuitry to behavior.

Heinricher MM.

Life Sci. 2003 Jun 27;73(6):813-22. Review.

PMID:
12801601
15.

Opiate modulating properties of nociceptin/orphanin FQ.

Harrison LM, Grandy DK.

Peptides. 2000 Jan;21(1):151-72. Review.

PMID:
10704732
16.

Substantia nigra control of basal ganglia nuclei.

Guatteo E, Cucchiaroni ML, Mercuri NB.

J Neural Transm Suppl. 2009;(73):91-101. Review.

PMID:
20411770
17.

[Paradigm of negative feedback via long-loop in the striatal dopamine release modulation in the rat].

Bueno-Nava A, Gonzalez-Pina R, Avila-Luna A, Alfaro-Rodriguez A.

Rev Neurol. 2011 Mar 16;52(6):371-7. Review. Spanish.

18.
19.

Role of nociceptin/orphanin FQ in thermoregulation.

Baiula M, Bedini A, Spampinato SM.

Neuropeptides. 2015 Apr;50:51-6. doi: 10.1016/j.npep.2015.03.005. Epub 2015 Mar 16. Review.

PMID:
25812480
20.

Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.

Gavioli EC, de Medeiros IU, Monteiro MC, Calo G, Romão PR.

Vitam Horm. 2015;97:241-66. doi: 10.1016/bs.vh.2014.11.003. Epub 2015 Jan 14. Review.

PMID:
25677775
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk